Tema Etfs LLC Summit Therapeutics Inc. Transaction History
Tema Etfs LLC
- $335 Billion
- Q1 2025
A detailed history of Tema Etfs LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Tema Etfs LLC holds 98,111 shares of SMMT stock, worth $1.79 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
98,111
Previous 26,641
268.27%
Holding current value
$1.79 Million
Previous $475 Million
298.09%
% of portfolio
0.57%
Previous 0.2%
Shares
2 transactions
Others Institutions Holding SMMT
# of Institutions
236Shares Held
86.8MCall Options Held
1.84MPut Options Held
3.13M-
Baker Bros. Advisors LP New York, NY24.4MShares$445 Million5.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$212 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$144 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$119 Million0.02% of portfolio
-
State Street Corp Boston, MA4.85MShares$88.4 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.67B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...